Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia

Charles-Edouard Luyt; Guillaume Hékimian; Nicolas Bréchot; Jean Chastre

doi:10.1055/s-0041-1740981

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2022; 43(02): 310-318
DOI: 10.1055/s-0041-1740981

Review Article

Viral Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia

Authors

Charles-Edouard Luyt

¹Service de Médecine Intensive Réanimation, Sorbonne Université, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris

²INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Paris
Guillaume Hékimian

¹Service de Médecine Intensive Réanimation, Sorbonne Université, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris

²INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Paris
Nicolas Bréchot

¹Service de Médecine Intensive Réanimation, Sorbonne Université, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris

²INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Paris
Jean Chastre

¹Service de Médecine Intensive Réanimation, Sorbonne Université, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Assistance Publique–Hôpitaux de Paris (AP-HP), Paris

²INSERM UMRS_1166-iCAN, Institute of Cardiometabolism and Nutrition, Paris

Abstract

Among the viruses possibly responsible for hospital-acquired and ventilator-associated pneumonia, herpes simplex virus (HSV) is probably the most often involved: HSV reactivation is frequent in intensive care unit patients, and lung parenchymal infection (HSV bronchopneumonitis) has been well described, either using cytological signs of parenchymal involvement in cells obtained during bronchoalveolar lavage or using HSV virus load in the lower respiratory tract. Although treating patients with HSV bronchopneumonitis may be recommended, based on expert opinion, prophylactic or preemptive treatment of HSV reactivation should be avoided. Ventilator-associated pneumonia due to cytomegalovirus (CMV) is less frequent than HSV bronchopneumonitis, and more difficult to diagnose. No data exists on the impact of antiviral treatment on CMV pneumonia. The involvement of respiratory viruses has been described in patients with healthcare-associated pneumonia and hospital-acquired pneumonia, but their role in ventilator-associated pneumonia is not clear.

Keywords

viral infection - herpes simplex virus - cytomegalovirus - respiratory viruses - mechanical ventilation

Full Text

References

References
1 Jennings LC, Anderson TP, Beynon KA. et al. Incidence and characteristics of viral community-acquired pneumonia in adults. Thorax 2008; 63 (01) 42-48
2 Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013; 13 (03) 260-268
3 Luyt CE, Combes A, Deback C. et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 2007; 175 (09) 935-942
4 Limaye AP, Kirby KA, Rubenfeld GD. et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 2008; 300 (04) 413-422
5 Libert N, Bigaillon C, Chargari C. et al. Epstein-Barr virus reactivation in critically ill immunocompetent patients. Biomed J 2015; 38 (01) 70-76
6 Ong DSY, Bonten MJM, Spitoni C. et al; Molecular Diagnosis and Risk Stratification of Sepsis Consortium. Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock. Clin Infect Dis 2017; 64 (09) 1204-1210
7 Coisel Y, Bousbia S, Forel J-M. et al. Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia. PLoS One 2012; 7 (12) e51340
8 Li X, Huang Y, Xu Z. et al. Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis. BMC Infect Dis 2018; 18 (01) 289
9 Bruynseels P, Jorens PG, Demey HE. et al. Herpes simplex virus in the respiratory tract of critical care patients: a prospective study. Lancet 2003; 362 (9395): 1536-1541
10 Porteous C, Bradley JA, Hamilton DN, Ledingham IM, Clements GB, Robinson CG. Herpes simplex virus reactivation in surgical patients. Crit Care Med 1984; 12 (08) 626-628
11 Ong GM, Lowry K, Mahajan S. et al. Herpes simplex type 1 shedding is associated with reduced hospital survival in patients receiving assisted ventilation in a tertiary referral intensive care unit. J Med Virol 2004; 72 (01) 121-125
12 Nash G. Necrotizing tracheobronchitis and bronchopneumonia consistent with herpetic infection. Hum Pathol 1972; 3 (02) 283-291
13 Luyt C-E, Bréchot N, Chastre J. What role do viruses play in nosocomial pneumonia?. Curr Opin Infect Dis 2014; 27 (02) 194-199
14 Simoons-Smit AM, Kraan EM, Beishuizen A, Strack van Schijndel RJ, Vandenbroucke-Grauls CM. Herpes simplex virus type 1 and respiratory disease in critically-ill patients: real pathogen or innocent bystander?. Clin Microbiol Infect 2006; 12 (11) 1050-1059
15 Tuxen DV, Cade JF, McDonald MI, Buchanan MR, Clark RJ, Pain MC. Herpes simplex virus from the lower respiratory tract in adult respiratory distress syndrome. Am Rev Respir Dis 1982; 126 (03) 416-419
16 Linssen CFM, Jacobs JA, Stelma FF. et al. Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Med 2008; 34 (12) 2202-2209
17 Tuxen DV, Wilson JW, Cade JF. Prevention of lower respiratory herpes simplex virus infection with acyclovir in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1987; 136 (02) 402-405
18 Hagel S, Scherag A, Schuierer L. et al. Effect of antiviral therapy on the outcomes of mechanically ventilated patients with herpes simplex virus detected in the respiratory tract: a systematic review and meta-analysis. Crit Care 2020; 24 (01) 584
19 Luyt CE, Forel JM, Hajage D. et al; Preemptive Treatment for Herpesviridae Study Group, Réseau Européen de Recherche en Ventilation Artificielle Network. Acyclovir for mechanically ventilated patients with herpes simplex virus oropharyngeal reactivation: a randomized clinical trial. JAMA Intern Med 2020; 180 (02) 263-272
20 Papazian L, Fraisse A, Garbe L. et al. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996; 84 (02) 280-287
21 Papazian L, Doddoli C, Chetaille B. et al. A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 2007; 35 (03) 755-762
22 Chiche L, Forel J-M, Roch A. et al. Active cytomegalovirus infection is common in mechanically ventilated medical intensive care unit patients. Crit Care Med 2009; 37 (06) 1850-1857
23 Papazian L, Jaber S, Hraiech S. et al; Preemptive Herpesviridae Treatment Study Group, REVA Network. Preemptive ganciclovir for mechanically ventilated patients with cytomegalovirus reactivation. Ann Intensive Care 2021; 11 (01) 33
24 Hall CB, Douglas Jr RG, Geiman JM, Messner MK. Nosocomial respiratory syncytial virus infections. N Engl J Med 1975; 293 (26) 1343-1346
25 Aitken C, Jeffries DJ. Nosocomial spread of viral disease. Clin Microbiol Rev 2001; 14 (03) 528-546
26 Limaye AP, Stapleton RD, Peng L. et al. Effect of ganciclovir on IL-6 levels among cytomegalovirus-seropositive adults with critical illness: a randomized clinical trial. JAMA 2017; 318 (08) 731-740
27 Cowley NJ, Owen A, Shiels SC. et al. Safety and efficacy of antiviral therapy for prevention of cytomegalovirus reactivation in immunocompetent critically ill patients: a randomized clinical trial. JAMA Intern Med 2017; 177 (06) 774-783
28 Horcajada JP, Pumarola T, Martínez JA. et al. A nosocomial outbreak of influenza during a period without influenza epidemic activity. Eur Respir J 2003; 21 (02) 303-307
29 Choi S-H, Hong S-B, Ko G-B. et al. Viral infection in patients with severe pneumonia requiring intensive care unit admission. Am J Respir Crit Care Med 2012; 186 (04) 325-332
30 Kim ES, Park KU, Lee SH. et al. Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP). PLoS One 2018; 13 (02) e0192893
31 Loubet P, Voiriot G, Houhou-Fidouh N. et al. Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: a single-center retrospective study. J Clin Virol 2017; 91: 52-57
32 Daubin C, Vincent S, Vabret A. et al. Nosocomial viral ventilator-associated pneumonia in the intensive care unit: a prospective cohort study. Intensive Care Med 2005; 31 (08) 1116-1122
33 Costa C, Sidoti F, Saldan A. et al. Clinical impact of HSV-1 detection in the lower respiratory tract from hospitalized adult patients. Clin Microbiol Infect 2012; 18 (08) E305-E307
34 Camps K, Jorens PG, Demey HE, Pattyn SR, Ieven M. Clinical significance of herpes simplex virus in the lower respiratory tract of critically ill patients. Eur J Clin Microbiol Infect Dis 2002; 21 (10) 758-759
35 Traen S, Bochanen N, Ieven M. et al. Is acyclovir effective among critically ill patients with herpes simplex in the respiratory tract?. J Clin Virol 2014; 60 (03) 215-221
36 Heininger A, Haeberle H, Fischer I. et al. Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis. Crit Care 2011; 15 (02) R77
37 Detection of herpes viruses by multiplex and real-time polymerase chain reaction in bronchoalveolar lavage fluid of patients with acute lung injury or acute respiratory distress syndrome Tachikaa R, Tomii K, Seo R et al. Respiration 2014; 87 (04) 279-286